Insider Trading History of Holden Lowell Thomas

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Holden Lowell Thomas since 2015. This trader's CIK number is 1479734. At the time of last reporting, Holden Lowell Thomas was the CFO of Nascent Biotech Inc.. (stock ticker symbol NBIO). Also see all insider trading activities at Nascent Biotech Inc..

Note that in the past HOLDEN LOWELL THOMAS also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Skkynet Cloud Systems, Inc. (SKKY) by Holden Lowell Thomas

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2022 SKKY 10,000 $1,700 0 $0 0 $0

Yearly summary of insider trading at Nascent Biotech Inc. (NBIO) by Holden Lowell Thomas

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2023 NBIO 170,000 $10,800 0 $0 0 $0
2022 NBIO 0 $0 5,000 $1,300 0 $0
2019 NBIO 10,000 $1,400 0 $0 0 $0
2019 NBIO 5,000 $825 0 $0 0 $0
2015 NBIO 617,346 $895,151 0 $0 0 $0


Insider trading activities at 2 companies by Holden Lowell Thomas:

1. Skkynet Cloud Systems, Inc. (SKKY)

2. Nascent Biotech Inc. (NBIO)

Table 1. Insider trading of Skkynet Cloud Systems, Inc. (SKKY) by Holden Lowell Thomas

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2022-04-01 SKKY Buy 10,000 .17 1,700

Table 2. Insider trading of Nascent Biotech Inc. (NBIO) by Holden Lowell Thomas

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2023-06-01 NBIO Buy 130,000 .04 5,200
2023-01-01 NBIO Buy 20,000 .14 2,800
2023-01-01 NBIO Buy 20,000 .14 2,800
2022-07-01 NBIO Sale 5,000 .26 1,300
2019-12-01 NBIO Buy 5,000 .17 825
2019-10-01 NBIO Buy 10,000 .14 1,400
2015-09-01 NBIO Buy 617,346 1.45 895,151

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Holden Lowell Thomas (CFO of Nascent Biotech Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.